MDE Manual

OMB Number: 0920-0612
Expiration Date: 12/31/2018

WISEWOMAN
Program
MDE Manual for DP18-1816
Edition 18.1

Item 1a: StFIPS

State/Tribal FIPS Code
This variable indicates the FIPS or tribal program code for the state or tribe where the administration
of the program is located.

SOURCE

National FIPS Code List

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

01 Alabama (AL)

Program administration located in Alabama

06 California (CA)

Program administration located in California

08 Colorado (CO)

Program administration located in Colorado

09 Connecticut (CT)

Program administration located in Connecticut

17 Illinois (IL)

Program administration located in Illinois

18 Indiana (IN)

Program administration located in Indiana

19 Iowa (IA)

Program administration located in Iowa

26 Michigan (MI)

Program administration located in Michigan

29 Missouri (MO)

Program administration located in Missouri

31 Nebraska (NE)

Program administration located in Nebraska

37 North Carolina (NC)

Program administration located in North Carolina

41 Oregon (OR)

Program administration located in Oregon

42 Pennsylvania (PA)

Program administration located in Pennsylvania

44 Rhode Island (RI)

Program administration located in Rhode Island

45 South Carolina (SC)

Program administration located in South Carolina

49 Utah (UT)

Program administration located in Utah

50 Vermont (VT)

Program administration located in Vermont

54 West Virginia (WV)

Program administration located in West Virginia

55 Wisconsin (WI)

Program administration located in Wisconsin

85 Southeast Alaska Regional Health
Consortium (SEARHC)

Program administration located within the tribal
area of SEARHC

92 Southcentral Foundation (SCF)

Program administration located within the tribal
area of SCF

ANALYSIS AND USE

To calculate the number of women screened by each state or tribal program
To assess the reach of the WISEWOMAN Program nationally and within a particular state or tribe

2

Item 1b: HdANSI

ANSI Geographic Code (Provider)
This indicates the ANSI geographic code of the provider that conducts the WISEWOMAN screening
office visit.

SOURCE

National ANSI Code List, Census Bureau

DENOMINATOR
POPULATION

The denominator includes all valid screenings

VALUES AND
DESCRIPTION

ANSI Geographic Code

ANALYSIS AND USE

To assess whether programs and specific providers are meeting screening goals in targeted
geographic areas
To identify geographic areas where women have access to the WISEWOMAN Program
To provide information for GIS analysis
To assist in identifying areas where there may be potential transportation barriers to accessing
WISEWOMAN services

Five-digit (character) value representing the geographic area of the
provider that conducts the screening office visit

3

Item 1c: EnrollSiteID

Enrollment Site ID
This variable indicates the site of a woman’s enrollment into the WISEWOMAN Program.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

Enrollment Site ID

ANALYSIS AND USE

To identify sites where outreach and enrollment are occurring
To identify sites where the Program is being administered and participants are tracked
To track the number of WISEWOMAN participants enrolled at each WISEWOMAN enrollment site

Valid five-digit ZIP code for the person administering enrollment of
participant

4

Item 1d: ScreenSiteID

Screening Site ID
This variable indicates the site where a woman received her WISEWOMAN screening.

SOURCE

National Provider Identifier

DENOMINATOR
POPULATION

The denominator includes all valid screenings

VALUES AND
DESCRIPTION

Screening Site ID

ANALYSIS AND USE

To identify the geographic locations of sites providing screening services to participants
To track the number of WISEWOMAN participants screened at each WISEWOMAN screening site
To describe differences in participant demographics or other characteristics by screening site
To provide information for GIS analysis
To identify the number of screening providers in a given geographic area
To identify provider pool for assessment of health systems and providers that use clinical systems of
care successful in blood pressure control

Value representing a National Provider Identifier for the provider who
conducts the screening office visit

5

Item 2a: TimePer

Time Period of Screening
This variable indicates the 6-month time period of the baseline screening for the participant.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all valid baseline screenings

VALUES AND
DESCRIPTION

1 6-month period 1

Baseline screening took place between 10/01/18 and 03/31/19

2 6-month period 2

Baseline screening took place between 04/01/19 and 09/30/19

3 6-month period 1

Baseline screening took place between 10/01/19 and 03/31/20

4 6-month period 2

Baseline screening took place between 04/01/20 and 09/30/20

5 6-month period 1

Baseline screening took place between 10/01/20 and 03/31/21

6 6-month period 2

Baseline screening took place between 04/01/21 and 09/30/21

7 6-month period 1

Baseline screening took place between 10/01/21 and 03/31/21

8 6-month period 2

Baseline screening took place between 04/01/22 and 09/30/22

9 6-month period 1

Baseline screening took place between 10/01/22 and 03/31/23

0 6-month period 2

Baseline screening took place between 04/01/23 and 09/30/23

ANALYSIS AND USE

To track participants over the course of the cooperative agreement by their baseline screenings
To track the number of unique participants programs have screened

6

Item 2b: NScreen

Number of Screening Cycles Received by the Participant
This variable indicates the total number of screening cycles that the participant has received since
the beginning of the cooperative agreement.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

Number of Visits

ANALYSIS AND USE

To track the number of screenings/rescreenings/follow-up assessments after a completed LSP/HC
that the participant has received

Value representing the number of screening cycles that the participant
has received since the beginning of the cooperative agreement (includes
current screening cycle).
Any values outside 01 to 08 will be flagged for a quality check

7

Item 2c: Type

Type of Screening Visit
This variable indicates whether the record represents a baseline screening visit, a rescreening visit,
or a post-Lifestyle Program (LSP)/Health Coaching (HC) follow-up assessment.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all valid screenings

VALUES AND

1 Screening

Record represents a baseline screening visit

DESCRIPTION

2 Rescreening

Record represents a rescreening visit

3 Follow-up assessment –
LSP/HC complete

Record represents a post-LSP/HC follow-up assessment with a
complete LSP/HC

4 Follow-up assessment –
LSP/HC incomplete

Record represents a post-LSP/HC follow-up assessment with an
incomplete LSP/HC

9 No answer recorded

No answer recorded
This value will be flagged as an error

ANALYSIS AND USE

To assess the number of unique women served by the WISEWOMAN Program
To track participants screening values over time
To link baseline screenings with rescreenings
To assess participants progress after completion of an LSP/HC

8

Item 2d: Navigation

Were the navigation services paid for by NBCCEDP funds, WISEWOMAN funds, Indian
Health Services/ Tribal funds, or other funds?
This variable indicates the funding source for navigation services for participants receive health
behavior support services, but whose cardiovascular screenings are not funded by WISEWOMAN.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all valid screenings

VALUES AND
DESCRIPTION

1 NBCCEDP funds

Participant received navigation services paid by NBCCEDP funds

2 WISEWOMAN funds

Participant received navigation services paid by WISEWOMAN funds

3 Indian Health
Service/Tribal funds

Participant received navigation services paid by Indian Health Services/
Tribal funds

4 Other funds

Participant received navigation services paid by other funds

5 Not Applicable

Not applicable because participant did not receive navigated services

ANALYSIS AND USE

To track participants served through the federally-funded WISEWOMAN program

9

Item 3a: EncodeID

Unique Participant ID Number
This variable indicates a woman’s unique identification number.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

Unique Participant ID
Number

ANALYSIS AND USE

To assess the number of unique women served by the WISEWOMAN Program
To track participants over time
To link baseline screenings with rescreenings
To link screenings with risk reduction counseling, lifestyle programs, health coaching, and
community-based resource referrals

Value representing the unique identifier for a participant

10

Item 3b: ResANSI

ANSI Geographic Code of Residence
This variable indicates the ANSI geographic code of residence of the WISEWOMAN participant.

SOURCE

National ANSI Code List

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

ANSI Geographic Code

ANALYSIS AND USE

To assess whether programs are meeting screening goals in targeted geographic areas
To identify the reach of the WISEWOMAN Program
To assist in identifying areas where there may be potential transportation barriers to accessing
WISEWOMAN services

Value representing the participant’s geographic area of residence

11

Item 3c: ZIP

ZIP Code of Residence
This variable indicates the participant’s ZIP code of residence.

SOURCE

National ZIP Code List

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

ZIP Code of Residence

Valid five-digit (character) ZIP code

99999

No ZIP code recorded
This value will be flagged as an error

ANALYSIS AND USE

To assess whether programs are meeting screening goals in targeted geographic areas
To identify the reach of the WISEWOMAN Program
To identify participant county of residence outside program state boundaries

12

Item 3d: MYB

Month and Year of Birth
This variable indicates the participant’s month and year of birth.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

Month and Year of Birth

ANALYSIS AND USE

To estimate the age of the participant; age will be calculated using the month and year of birth and
office visit date (BPDate)
To assist in characterizing the population reached by the WISEWOMAN Program
To provide data element required to determine participant’s cardiovascular risk or risk score
To assess whether the participants are within the Program’s priority age group

Month and Year of Birth in MMCCYY format
Example: September 01, 1965 = 091965

13

Item 3e: Latino

Hispanic or Latino Origin
This variable indicates whether the participant is of Hispanic or Latino origin.

SOURCE

United States Office of Management and Budget Guidelines

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

1 Yes

Participant reports that she is of Hispanic or Latino origin

2 No

Participant reports that she is not of Hispanic or Latino origin

7 Unknown

Participant is unsure whether she is of Hispanic or Latino origin

9 No answer recorded

Participant has not reported whether she is of Hispanic or Latino origin
This value will be flagged as an error

ANALYSIS AND USE

To assess the race/ethnicity of WISEWOMAN participants
To analyze screening, lifestyle programs, and other variables by ethnicity
To assist in characterizing the population reached by the WISEWOMAN Program
To provide data element required to determine participant’s cardiovascular risk or risk score

14

Item 3f: Race1

Race: First Race
This variable indicates a race with which the participant identifies.

SOURCE

United States Census Bureau; United States Office of Management and Budget Guidelines

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

1 White

Participant identifies White as a race

2 Black or African American

Participant identifies Black or African American as a race

3 Asian

Participant identifies Asian as a race

4 Native Hawaiian or Other
Pacific Islander

Participant identifies Native Hawaiian or Other Pacific Islander as a
race

5 American Indian or Alaska
Native

Participant identifies American Indian or Alaska Native as a race

7 Unknown

Participant does not know her race or does not identify with any of
the races listed above
If a participant is Hispanic and does not identify a race, this code
should be used

9 No answer recorded

Race information is missing for the participant
Any race information gathered should be entered beginning with the
Race1 field
See cross edits related to this value

ANALYSIS AND
USE

To assess the race/ethnicity of WISEWOMAN participants
To understand and analyze screening, lifestyle programs, and other variables by race
To assist in characterizing the population reached by the WISEWOMAN Program
To provide data element required to determine participant’s cardiovascular risk or risk score

15

Item 3g: Race2

Race: Second Race
This variable indicates a race with which the participant identifies in cases where a participant is
multiracial.

SOURCE

United States Census Bureau; United States Office of Management and Budget Guidelines

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

1 White

Participant identifies White as a race
Participant who has identified two or more races can have this value

2 Black or African
American

Participant identifies Black or African American as a race
Participant who has identified two or more races can have this value

3 Asian

Participant identifies Asian as a race
Participant who has identified two or more races can have this value

4 Native Hawaiian or
Other Pacific Islander

Participant identifies Native Hawaiian or Other Pacific Islander as a
race
Participant who has identified two or more races can have this value

5 American Indian or
Alaska Native

Participant identifies American Indian or Alaska Native as a race
Participant who has identified two or more races can have this value

7 Unknown

Participant does not know her race or does not identify with any of
the races listed above

9 No answer recorded

If race information is missing for Race2
Participant has not identified any race
Participant has identified one race and does not identify other races
If a participant does not identify a second race, ‘9 No answer
recorded’ should be used for this field and all subsequent race fields

ANALYSIS AND USE

To assess the race/ethnicity of WISEWOMAN participants
To understand and analyze screening, lifestyle programs, and other variables by race
To assist in characterizing the population reached by the WISEWOMAN Program
To provide data element required to determine participant’s cardiovascular risk or risk score

16

Item 3h: Education

Education (highest grade completed)
This variable indicates the highest grade the participant completed.

SOURCE

CDC Behavioral Risk Factor Surveillance System

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

1 <9th grade

Participant reports that she did not attend high school

2 Some high school

Participant reports she attended high school, but did not graduate

3 High school graduate
or equivalent

Participant reports that she graduated from high school or has the
equivalent of a high school diploma, and she did not attend any
college or higher education

4 Some college or higher

Participant reports that she attended one or more years of college
and/or graduate school (e.g., college graduate, graduate degree)

7 Don’t know/Not sure

Participant reports that she does not know the highest grade she
completed
This value will be flagged as a quality check

8 Don’t want to answer

Participant does not want to answer the highest grade she completed
This value will be flagged as a quality check

9 No answer recorded

Education information is missing for the participant
This value will be flagged as an error

ANALYSIS AND USE

To assess the educational attainment of women in the WISEWOMAN population
To understand screening, lifestyle programs , and other variables by education status
To help determine the literacy level needed for materials developed for recruitment, risk reduction
counseling, lifestyle programs, health coaching, and community-based resources
To assist in characterizing the population reached by the WISEWOMAN Program

17

Item 3i: Language

What is the primary language spoken in your home?
This variable indicates the primary language spoken in the participant’s home.

SOURCE

National Survey of Children’s Health

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

01 English

Participant identifies English as the primary language spoken in her
home

02 Spanish

Participant identifies Spanish as the primary language spoken in her
home

03 Arabic

Participant identifies Arabic as the primary language spoken in her
home

04 Chinese

Participant identifies Chinese as the primary language spoken in her
home

05 French

Participant identifies French as the primary language spoken in her
home

06 Italian

Participant identifies Italian as the primary language spoken in her
home

07 Japanese

Participant identifies Japanese as the primary language spoken in
her home

08 Korean

Participant identifies Korean as the primary language spoken in her
home

09 Polish

Participant identifies Polish as the primary language spoken in her
home

10 Russian

Participant identifies Russian as the primary language spoken in her
home

11 Tagalog

Participant identifies Tagalog as the primary language spoken in her
home

12 Vietnamese

Participant identifies Vietnamese as the primary language spoken in
her home

13 Creole

Participant identifies Creole as the primary language spoken in her
home

14 Portuguese

Participant identifies Portuguese as the primary language spoken in
her home

15 Hmong

Participant identifies Hmong as the primary language spoken in her
home

16 Other Language

Participant identifies another language as the primary language
spoken in her home (write-in response)

88 Don’t want to answer

Participant does not want to answer the primary language spoken in
her home
This value will be flagged as a quality check

99 No answer recorded

Primary language information is missing for the participant
This value will be flagged as an error

ANALYSIS AND USE

To assess the primary language of women in the WISEWOMAN population
To provide context to potential the health literacy issues
To assist in characterizing the population reached by the WISEWOMAN Program

18

Item 4a: SRC

Which of the following conditions do you have:
i.
Hypertenion
ii.
High cholesterol
iii.
Diabetes (Type 1 or Type 2)
This variable indicates whether the participant has hypertension, high cholesterol, and/ or diabetes.

SOURCE

American Heart Association

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION
(CODE FOR EACH
CONDITION)

1 Yes

Participant has the condition

2 No

Participant does not have the condition

7 Don’t know/Not sure

Participant does not know whether she has condition
This value will be flagged as a quality check

8 Don’t want to answer

Participant does not want to answer whether she has the condition
This value will be flagged as a quality check

9 No answer recorded

No answer recorded
This value will be flagged as an error

ANALYSIS AND USE

To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population
To assess the number of cases of hypertension, high cholesterol, and diabetes that have been
previously diagnosed as opposed to newly detected cases among the WISEWOMAN population
To assess control of and improvements in blood pressure, cholesterol, and diabetes for newly and
previously diagnosed women
To provide data element required to determine participant’s cardiovascular risk score

19

Item 4b: SRHA

Have you had any of the following:
i.
Stroke/ TIA
ii.
Heart attack
iii.
Coronary heart disease
iv.
Heart failure
v.
Vascular disease (peripheral arterial disease)
vi.
Congenital heart disease and defects
This variable indicates whether the participant has ever been diagnosed by a healthcare provider as
having stroke/ TIA, heart attack, coronary heart disease, heart failure, vascular disease (peripheral
arterial disease), and/ or congenital heart disease and defects.

SOURCE

American Heart Association

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION
(CODE FOR EACH
CONDITION)

1 Yes

Participant has been diagnosed by a healthcare provider as having
the condition

2 No

Participant has never been diagnosed by a healthcare provider as
having each condition

7 Don’t know/Not sure

Participant does not know whether she has been diagnosed by a
healthcare provider as having the condition
This value will be flagged as a quality check

8 Don’t want to answer

Participant does not want to answer whether she has been
diagnosed by a healthcare provider as the condition
This value will be flagged as a quality check

9 No answer recorded

No answer recorded
This value will be flagged as an error

ANALYSIS AND USE

To understand the history of cardiovascular disease among individual participants and the overall
WISEWOMAN population
To assess the number of participants who have been previously diagnosed as having
cardiovascular disease
To provide data element required to determine participant’s cardiovascular risk score

20

Item 5a: Meds

Was medication prescribed to lower:
i.
Blood pressure
ii.
Cholesterol (Statin)
iii.
Cholesterol (other prescribed medication)
iv.
Blood sugar
This variable indicates whether the participant takes medication to lower her blood pressure,
cholesterol, and/or blood sugar.

SOURCE

American Heart Association

DENOMINATOR
POPULATION

The denominator includes WISEWOMAN participants with hypertension (high blood pressure), high
cholesterol, or diabetes or participants who were previously diagnosed with hypertension (high blood
pressure), high cholesterol, or diabetes

VALUES AND
DESCRIPTION
(CODE FOR EACH
CONDITION)

1 Yes

Participant is taking medication for the condition

2 No

Participant is not taking medication for the condition

5 Not Applicable

This question is not applicable for the patient because she has never
been diagnosed with for the condition, either because she does not
have for the condition (as assessed with a measurement at screening/
rescreening) or because she reports that she has never been
diagnosed with for the condition (as assessed with self-report at
screening/ rescreening).

7 Don’t know/Not sure

Participant does not know whether she is taking medication for the
condition
This value will be flagged as a quality check

8 Don’t want to answer

Participant does not want to answer whether she is taking medication
for the condition
This value will be flagged as a quality check

9 No answer recorded

No answer recorded
This value will be flagged as an error

ANALYSIS AND USE

To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population
To assess the number of cases of hypertension, high cholesterol, and diabetes that have been
previously diagnosed as opposed to newly detected cases among the WISEWOMAN population
To assess the control and management of blood pressure, cholesterol, and diabetes among
participants who have hypertension, high cholesterol, or diabetes
To assist in assessment of adherence to medication for hypertension, high cholesterol, and diabetes
To provide data element required to determine participant’s cardiovascular risk score

21

Item 5b: Aspirin

Are you taking aspirin daily to help prevent a heart attack or stroke?
This variable indicates whether the participant is taking aspirin daily to help prevent a heart attack or
stroke.

SOURCE

American College of Cardiology

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

1 Yes

Participant is taking aspirin daily to help prevent a heart attack or
stroke

2 No

Participant is not taking aspirin daily to help prevent a heart attack or
stroke

7 Don’t know/Not sure

Participant does not know whether she is taking aspirin daily to help
prevent a heart attack or stroke
This value will be flagged as a quality check

8 Don’t want to answer

Participant does not want to answer whether she is taking aspirin
daily to help prevent a heart attack or stroke
This value will be flagged as a quality check

9 No answer recorded

No answer recorded
This value will be flagged as an error

ANALYSIS AND USE

To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population

22

Item 5c: MedAdhere

During the past 7 days, how many days didyou take prescribed mediation for the
following conditions:
i.
High blood pressure (0 – 7 days)
ii.
High Cholesterol (0 – 7 days)
iii.
High blood sugar (0 – 7 days)
This variable indicates the number of days out of the past 7 days, including the day of
the screening, that the participant took prescribed medication to lower her blood
pressure, cholesterol, and/or blood sugar.

SOURCE

Adapted from National Survey of Children’s Health

DENOMINATOR POPULATION

The denominator includes WISEWOMAN participants taking medication to lower blood
pressure, cholesterol, or blood sugar

VALUES AND DESCRIPTION
(CODE FOR EACH CONDITION)

Number of days (01-07)

A numeric value indicating the number of days out of the
past 7 days, including the day of the screening, that the
participant took prescribed medication for the condition
Any value outside the valid range (01 – 07) will be
considered an error

00 None

In the past 7 days, including the day of the screening, the
participant did not take prescribed medication for the
condition

55 Not Applicable

This question is not applicable for the patient because she
has never been diagnosed with high cholesterol and/or has
indicated that she does not take medication for high
cholesterol

77 Don’t know/Not sure

Participant is not sure whether she took prescribed
medication to lower her cholesterol during the past 7 days
including the day of the screening
This value will be flagged as a quality check

88 Don’t want to answer

Participant did not want to answer whether she took
prescribed medication for the condition during the past 7
days, including the day of the screening
This value will be flagged as a quality check

99 Not applicable

This question is not applicable for the patient because she
has never been diagnosed with the condition (high blood
pressure, high cholesterol, or high blood sugar) and/or has
indicated that she does not take medication for the
condition

ANALYSIS AND USE

To facilitate assessment of adherence to medication prescribed for high blood pressure,
high cholesterol, and diabetes
To assist in determining management and control for high blood pressure, high
cholesterol, and diabetes

23

Item 5d: Monitored

After being prescribed medication, on what date(s) did the participant have her blood
pressure re-measured either by a healthcare provider, or with another community resource?
This variable indicates the date when blood pressure is re-measured for a participant who is
prescribed blood pressure medication.

SOURCE

WISEWOMAN-specific variable for blood pressure follow-up

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants taking medication to lower blood pressure

VALUES AND
DESCRIPTION

Blood Pressure
Monitoring Dates

ANALYSIS AND USE

To assist in determining management and control for high blood pressure

Valid date in MMDDCCYY format
Date when blood pressure is re-measured by a health care provider
or another community resource
Example: September 10, 2013 = 09102013

24

Item 6a: BPHome

Do you measure your blood pressure at home or using other calibrated sources?
This variable indicates whether the participant monitors her blood pressure at home or using other
calibrated sources (select all response options that apply).

SOURCE

HealthStyles Survey

DENOMINATOR
POPULATION

The denominator includes WISEWOMAN participants with high blood pressure or previously
diagnosed with hypertension (high blood pressure)

VALUES AND
DESCRIPTION

1 Yes

Participant reports that she measures her blood pressure at home or
using other calibrated sources

2 No – Was never told to
measure her blood
pressure

Participant reports that she does not measure her blood pressure at
home or using other calibrated sources because she was never told
she should measure her blood pressure

3 No – Doesn’t know how
to measure her blood
pressure

Participant reports that she does not measure her blood pressure at
home or using other calibrated sources because she does not know
how to measure her blood pressure

4 No – Doesn’t have
equipment to measure
her blood pressure

Participant reports that she does not measure her blood pressure at
home or using other calibrated sources because she does not have
access to the required equipment to measure her blood pressure

5 Not Applicable

This question is not applicable for the patient because she has never
been diagnosed with hypertension (high blood pressure)

7 Don’t know/Not
sure/Other

Participant is not sure whether she measures her blood pressure at
home or using other calibrated sources or provides some other
reason for why she does not measure her blood pressure at home
(for example, participant chooses not to measure her blood at home)
This value will be flagged as a quality check

8 Don’t want to answer

Participant did not want to answer whether she measures her blood
pressure at home or using other calibrated sources
This value will be flagged as a quality check

9 No answer recorded

No answer recorded
This value will be flagged as an error

ANALYSIS AND USE

To determine self-control and management of hypertension (high blood pressure)

25

Item 6b: BPFreq

How often do you measure your blood pressure at home or using other calibrated sources?
This variable indicates how frequently the participant measures her blood pressure at home or using
other calibrated sources.

SOURCE

HealthStyles Survey

DENOMINATOR
POPULATION

The denominator includes WISEWOMAN participants with high blood pressure or previously
diagnosed with hypertension (high blood pressure)

VALUES AND
DESCRIPTION

1 Multiple times per day

Participant measures her blood pressure at home or using other
calibrated sources multiple times per day

2 Daily

Participant measures her blood pressure at home or using other
calibrated sources once per day

3 A few times per week

Participant measures her blood pressure at home or using other
calibrated sources a few times per week

4 Weekly

Participant measures her blood pressure at home or using other
calibrated sources once per week

5 Monthly

Participant measures her blood pressure at home or using other
calibrated sources once per month

6 Not Applicable

This question is not applicable for the patient because she has never
been diagnosed with hypertension (high blood pressure) or does not
monitor her blood pressure at home or using other calibrated sources

7 Don’t know/Not
sure/Other

Participant is not sure how frequently she measures her blood
pressure at home or using other calibrated sources
This value will be flagged as a quality check

8 Don’t want to answer

Participant did not want to answer how frequently she measures her
blood pressure at home or using other calibrated sources
This value will be flagged as a quality check

9 No answer recorded

No answer recorded
This value will be flagged as an error

ANALYSIS AND USE

To determine self-control and management of hypertension (high blood pressure)

26

Item 6c: BPSend

Do you regularly share blood pressure readings with a health care provider for feedback?
This variable indicates whether the participant shares blood pressure readings taken at home or
using other calibrated sources with a health care provider for feedback almost every time she sees
her provider.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes WISEWOMAN participants with high blood pressure or previously
diagnosed with hypertension (high blood pressure)

VALUES AND
DESCRIPTION

1 Yes

Participant reports that she shares blood pressure readings taken at
home or using other calibrated sources with a health care provider for
feedback almost every time she sees her provider

2 No

Participant reports that she does not share blood pressure readings
taken at home or using other calibrated sources with a health care
provider for feedback

5 Not Applicable

This question is not applicable for the patient because she has never
been diagnosed with hypertension (high blood pressure) or does not
monitor her blood pressure at home or using other calibrated sources

7 Don’t know/Not
sure/Other

Participant is not sure whether she shares blood pressure readings
taken at home or using other calibrated sources with a health care
provider for feedback
This value will be flagged as a quality check

8 Don’t want to answer

Participant did not want to answer whether she shares blood
pressure readings taken at home or using other calibrated sources
with a health care provider for feedback
This value will be flagged as a quality check

9 No answer recorded

No answer recorded
This value will be flagged as an error

ANALYSIS AND USE

To determine self-control and management of hypertension (high blood pressure)
To determine whether blood pressure monitoring results are shared with a health care provider for
monitoring of progress

27

Item 7a: FruitVeg

How many cups of fruits and vegetables do you eat in an average day?
This variable indicates the amount of fruit and vegetables the participant consumes in an average
day.

SOURCE

American Heart Association

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

Number of cups

Two-digit (numeric) value representing the number of cups of fruit
and vegetables the participant consumes in an average day
Any value outside the valid range (01 -65) will be considered an error
Example: 2 cups = 02

00 None

Participant does not consume fruit or vegetables in an average day

88 Don’t want to answer

Participant does not want to answer how many cups of fruit and
vegetables she consumes in an average day
This value will be flagged as a quality check

99 No answer recorded

No answer recorded
This value will be flagged as an error

ANALYSIS AND USE

To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s cardiovascular risk score

28

Item 7b: Fish

Do you eat fish at least two times a week?
This variable indicates whether the participant consumes two servings or more of fish weekly.

SOURCE

American Heart Association

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

1 Yes

Participant consumes two servings or more of fish weekly

2 No

Participant does not consume two servings or more of fish weekly

8 Don’t want to answer

Participant does not want to answer whether she consumes two
servings or more of fish weekly
This value will be flagged as a quality check

9 No answer recorded

No answer recorded
This value will be flagged as an error

ANALYSIS AND USE

To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s cardiovascular risk score

29

Item 7c: Grains

Thinking about all the servings of grain products you eat in a typical day, how many are
whole grains?
This variable indicates the relative amount of whole grains the participant consumes compared to
the total amount of grains consumed in a typical day.

SOURCE

United State’s Department of Agriculture

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

1 Less than half

Less than half of servings of grain products consumed in a typical
day are whole grains

2 About half

About half of servings of grain products consumed in a typical day
are whole grains

3 More than half

More than half of servings of grain products consumed in a typical
day are whole grains

8 Don’t want to answer

Participant does not want to answer how many servings of grain
products consumed in a typical day are whole grains
This value will be flagged as a quality check

9 No answer recorded

No answer recorded
This value will be flagged as an error

ANALYSIS AND USE

To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s cardiovascular risk score

30

Item 7d: Sugar

Do you drink less than 36 ounces (450 calories) of sugar sweetened beverages weekly?
This variable indicates whether the participant drinks less than 36 ounces (450 calories) of sugar
sweetened beverages weekly.

SOURCE

American Heart Association

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

1 Yes

Participant consumes less than 36 ounces (450 calories) of
beverages with added sugars in an average week

2 No

Participant consumes 36 ounces or more (450 calories or more) of
beverages with added sugars in an average week

8 Don’t want to answer

Participant does not want to answer whether she consumes less than
36 ounces (450 calories) or more of beverages with added sugars in
an average week
This value will be flagged as a quality check

9 No answer recorded

No answer recorded
This value will be flagged as an error

ANALYSIS AND USE

To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s cardiovascular risk score

31

Item 7e: SaltWatch

Are you currently watching or reducing your sodium or salt intake?
This variable indicates whether the participant is currently watching or reducing her sodium or salt
intake.

SOURCE

CDC Behavioral Risk Factor Surveillance System

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

1 Yes

Participant is currently watching or reducing her sodium or salt intake

2 No

Participant is not currently watching or reducing her sodium or salt
intake

8 Don’t want to answer

Participant does not want to answer whether she is currently
watching or reducing her sodium or salt intake
This value will be flagged as a quality check

9 No answer recorded

No answer recorded
This value will be flagged as an error

ANALYSIS AND USE

To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population

32

Item 7f: AlcDay

In the past 7 days, how often do you have a drink containing alcohol?
This variable indicates the number of days during the past 7 days that a participant had a drink
containing alcohol.

SOURCE

Alcohol Use Disorders Identification Test

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

Number of days

A two-digit (numeric) value representing the number of days during
the past 7 days that the participant consumed a drink contained
alcohol
Example: 4 days = 04

00 None

Participant has not consumed any drinks containing alcohol during
the past 7 days

88 Don’t want to answer

Participant does not want to answer how many days during the past 7
days she has consumed drinks containing alcohol
This value will be flagged as a quality check

999 No answer recorded

No answer recorded
This value will be flagged as an error

ANALYSIS AND USE

To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population

33

Item 7g: AlcFreq

How many alcoholic drinks, on average, do you consume during a day you drink?
This variable indicates the average number of alcoholic drinks consumed during a day.

SOURCE

Alcohol Use Disorders Identification Test

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

Number of drinks

A numeric value indicating the average number of alcoholic
drinks consumed during a day when the participant is drinking
alcohol
Any value outside the valid range (00 – 07) will be considered
an error

00 None

The participant does not consume any alcoholic drinks

88 Don’t want to answer

Participant did not want to answer the average number of
alcoholic drinks she consumes during a day when she is
drinking alcohol
This value will be flagged as a quality check

99 No answer recorded

No answer recorded
This value will be flagged as an error

ANALYSIS AND USE

To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population

34

Item 8a: PA

How many minutes of physical activity (exercise) do you get in a week?
This variable indicates the amount of physical activity the participant gets during an average week.

SOURCE

American Heart Association Life’s

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

Number of minutes

A four-digit (numeric) value representing the minutes of physical
activity the participant gets during an average week
Any value outside the valid range (0010 – 1700) will be considered a
quality check
Example: 30 minutes = 0030
If the number of minutes of physical activity exceeds 1700 minutes,
PA should be coded as 1700 and the number of minutes of physical
activity should be documented using the Validation of Data form. See
Appendix B for the procedure for validating out-of-range values.

0000 None

Participant does not get any physical activity during an average week

8888 Don’t want to
answer

Participant does not want to answer how much physical activity she
gets during an average week
This value will be flagged as a quality check

9999 No answer recorded

No answer recorded
This value will be flagged as an error

ANALYSIS AND USE

To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s cardiovascular risk score

35

Item 9a: Smoker

Do you smoke? Includes cigarettes, pipes, or cigars (smoked tobacco in any form)
This variable indicates whether the participant smokes tobacco in any form, including cigarettes,
pipes, or cigars.

SOURCE

American Heart Association

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

1 Current Smoker

Participant currently smokes tobacco in any form, including
cigarettes, pipes, or cigars

2 Quit (1-12 months ago)

Participant quit smoking tobacco in any form, including cigarettes,
pipes, or cigars, 1 to 12 months ago

3 Quit (More than 12
months ago)

Participant quit smoking tobacco in any form, including cigarettes,
pipes, or cigars, more than 12 months ago

4 Never Smoked

Participant has never smoked tobacco in any form, including
cigarettes, pipes, or cigars

8 Don’t want to answer

Participant does not want to answer whether she smokes tobacco in
any form, including cigarettes, pipes, or cigars
This value will be flagged as a quality check

9 No answer recorded

No answer recorded
This value will be flagged as an error

ANALYSIS AND USE

To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population
To identify participants who might benefit from smoking cessation counseling and tobacco cessation
resources (quit line and community-based)
To provide data element required to determine participant’s cardiovascular risk score

36

Item 10a: PHQ

Over the past 2 weeks, how often have you been bothered by any of the following problems?
I.
Little interest or pleasure in doing things (not at all, several days, more than half, or
nearly every day)?
II.
Feeling down, depressed, or hopeless (not at all, several days, more than half, or
nearly every day)?
This variable indicates the number of days during the past two weeks that the participant felt little
interest of pleasure in doing things and felt down, depressed, or hopeless.

SOURCE

Patient Health Questionnaire (PHQ-2)

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION
(CODE FOR EACH
ISSUE)

0 Not at all

Participant has not been bothered by this issue at all over the past
two weeks

1 Several days

Participant has been bothered by this issue several days over the
past two weeks

2 More than half

Participant has been bothered by this issue more than half the days
over the past two weeks

3 Nearly every day

Participant has been bothered by this issue nearly every day over the
past two weeks

8 Don’t want to answer

Participant does not want to answer how often she has been
bothered by this issue
This value will be flagged as a quality check

9 No answer recorded

No answer recorded
This value will be flagged as an error

ANALYSIS AND USE

To determine the health status of individual participants and the overall WISEWOMAN population
To provide health status information for cost benefit or cost effectiveness analyses

37

Item 11a: Height

Height
This variable indicates the participant’s height in inches at baseline screening.

SOURCE

American Heart Association

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

Height in inches

Up to a two-digit (numeric) value representing the participant’s height
at baseline screening
Height values between 48" and 58" or 74" and 76" will be flagged for
quality checks and program verification. See Appendix B for the
procedure for validating out-of-range values. Any values outside 48"76" will be considered an error
Example: 62" (5 feet, 2 inches) = 62

77 Unable to obtain

Height measurement was attempted, but measurement results were
not obtained. See Appendix B for the procedure for documenting the
reason that the measurement was not obtained
This value will be flagged as an error

88 Client refused

Participant refuses to have her height measurement taken
This value will be flagged as an error

99 No measurement
recorded

Height measurement was not performed
This value will be flagged as an error

ANALYSIS AND USE

To calculate the BMI of WISEWOMAN participants
To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s cardiovascular risk score

38

Item 11b: Weight

Weight
This variable indicates the participant’s weight in pounds.

SOURCE

American Heart Association Life’s

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

Weight in pounds

Up to a three-digit (numeric) value representing the participant’s
weight
Weight values between 74 and 90 lb or 350 and 460 lb will be flagged
for quality checks and program verification. See Appendix B for the
procedure for validating out-of-range values. Any values outside 74460 lb will be considered an error
Example: 98 lb = 098

777 Unable to obtain

Weight measurement was attempted, but measurement results were
not obtained
This value will be flagged as a quality check. See Appendix B for the
procedure for documenting the reason that the measurement was not
obtained

888 Client refused

Participant refuses to have her weight measurement taken
This value will be flagged as a quality check

999 No measurement
recorded

Weight measurement was not performed
This value will be flagged as an error

ANALYSIS AND USE

To calculate the BMI of WISEWOMAN participants
To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s cardiovascular risk score

39

Item 11c: Waist

Waist Circumference
This variable indicates the participant’s waist circumference in inches.

SOURCE

Not applicable; health screening measurement

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

Waist Circumference in inches

Up to a two-digit (numeric) value representing the participant’s
waist circumference in inches
Any value outside the valid range (16 – 71 inches) will be
flagged as a quality check
Example: 30 inches = 30

77 Unable to obtain

Waist circumference measurement was attempted, but
measurement results were not obtained

88 Client refused

Participant refuses to have her waist circumference
measurement taken

99 No measurement recorded

Waist circumference measurement was not performed

ANALYSIS AND USE

To determine waist-hip ratio for the participant
To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population

40

Item 12a: BPDate

Clinical Assessment Date (Office Visit Date)
This variable indicates the date of the office visit or the date of the follow-up assessment for a
particpant.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

Clinical assessment
date/Office visit date

ANALYSIS AND USE

To identify the date of the office visit
To facilitate analysis of changes in blood pressure over time
To calculate other service time frames, including time to rescreening, lifestyle program sessions,
lifestyle program/health coaching follow-up assessment, risk reduction counseling sessions, alert
referrals, and labs

Valid date in MMDDCCYY format
Date of the office visit or the date of the follow-up assessment for a
participant
Example: September 10, 2013 = 09102013

41

Item 12b: SBP

Systolic Blood Pressure
This variable indicates the participant’s systolic blood pressure readings.

SOURCE

Not applicable; health screening measurement

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION
(CODE FOR EACH
READING AND IN
THE ORDER TAKEN)

Systolic blood
pressure in
mmHg

A three-digit (numeric) value representing the participant’s systolic blood
pressure in mmHg
Systolic blood pressure values between 230 and 260 mmHg will be flagged for
quality checks and program verification. Values outside 74-260 mmHg will be
flagged as errors. See Appendix B for the procedure for validating out-of-range
values
If a blood pressure measurement was not obtained at the time of the office visit
and obtained at a referral visit within 30 days of the visit, the blood pressure
measurement from the referral should be recorded here
Example: 90 mmHg = 090

777 Unable to
obtain

Systolic blood pressure measurement was attempted, but results were not
obtained due to technical difficulties or errors
See Appendix B for the procedure for documenting the reason that the
measurement could not be obtained
This value will be flagged as an error

888 Client
refused

Participant refuses to have her systolic blood pressure measurement taken
This value will be flagged as an error

999 No
measurement
recorded

Systolic blood pressure measurement was not performed or not recorded
This value will be flagged as an error

ANALYSIS AND USE

To identify those at increased risk for cardiovascular conditions, including heart attack, heart failure,
stroke, and kidney disease
To identify participants who would benefit from lifestyle programs
To identify participants unaware that they have hypertension (high blood pressure) for referral to
medical management
To determine control and management of blood pressure
To identify participants who require further diagnostic evaluation
To identify hypertension (high blood pressure) risk of the WISEWOMAN population
To provide data element required to determine participant’s cardiovascular risk score

42

Item 12c: DBP

Diastolic Blood Pressure
This variable indicates the participant’s diastolic blood pressure readings.

SOURCE

Not applicable; health screening measurement

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION
(CODE FOR EACH
READING AND IN THE
ORDER TAKEN)

Diastolic blood pressure
in mmHg

A three-digit (numeric) value representing the participant’s diastolic
blood pressure in mmHg
Diastolic blood pressure values between 2-12 mmHg or 122-156
mmHg will be flagged for quality checks and program verification.
Values outside 2-156 mmHg will be considered errors. See Appendix
B for the procedure for validating out-of-range values
If a blood pressure measurement was not obtained at the time of the
office visit and obtained at a referral visit within 30 days of the visit,
the blood pressure measurement from the referral should be
recorded here
Example: 85 mmHg = 085

777 Unable to obtain

Diastolic blood pressure measurement was attempted, but results
were not obtained due to technical difficulties or errors
See Appendix B for the procedure for documenting the reason that
the measurement could not be obtained
This value will be flagged as an error

888 Client refused

Participant refuses to have her diastolic blood pressure measurement
taken
This value will be flagged as an error

999 No measurement
recorded

Diastolic blood pressure measurement was not performed or not
recorded
This value will be flagged as an error

ANALYSIS AND USE

To identify those at increased risk for cardiovascular conditions, including heart attack, heart failure,
stroke, and kidney disease
To identify participants who would benefit from lifestyle programs
To identify participants unaware that they have hypertension(high blood pressure) for referral to
medical management
To determine control and management of blood pressure
To identify participants who require further diagnostic evaluation
To identify hypertension (high blood pressure) risk of the WISEWOMAN population
To provide data element required to determine participant’s cardiovascular risk score

43

Item 13a: Fast

Fasting Status
This variable indicates whether a participant fasted for at least nine hours prior to having blood
drawn for cholesterol or glucose measurements.

SOURCE

Not applicable; health screening measurement

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

1 Yes

Participant fasted for at least nine hours prior to having blood drawn

2 No

Participant did not fast for at least nine hours prior to having blood
drawn

9 No answer recorded

No answer recorded
Provider failed to confirm fasting status or no information is available
from the provider
This value should be marked if 14b: TotChol, 14c: HDL, 14d: LDL,
14e: Trigly, and 14b: Glucose all are equal to 999/9999, 777/7777, or
888/8888
This value will be flagged as a quality check

ANALYSIS AND USE

To facilitate accurate identification of participants who have high cholesterol, borderline high
cholesterol, diabetes, or pre-diabetes

44

Item 14a: TotChol

Total Cholesterol (fasting or nonfasting)
This variable indicates the participant’s total cholesterol level.

SOURCE

Not applicable; health screening measurement

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

Total
cholesterol in
mg/dL

A three-digit (numeric) value representing the participant’s total cholesterol in
mg/dL
Total cholesterol values that are between 44 and 60 mg/dL or 400 and 702 mg/dL
will be flagged for quality checks and program verification. Values outside 44-702
will be considered errors. See Appendix B for the procedure for validating out-ofrange values
Example: 90 mg/dL = 090

777
Inadequate
blood sample

Total cholesterol measurement was attempted, but results were not obtained due
to technical difficulties or errors
This may include issues such as (1) two or more failed venipuncture attempts; (2)
insufficient amount of blood, type of test tube; (3) invalid Cholestech readings due
to very high/low values; (4) sample submitted to laboratory, test not done due to
erroneous or missing laboratory request or other paperwork
See Appendix B for the procedure for documenting the reason that the
measurement was not obtained
This value will be flagged as a quality check

888 Client
refused

Participant refuses to have her blood drawn for cholesterol measurements
If the participant refuses to go to the lab, the participant can be considered to have
refused
If the participant does not go to the scheduled lab appointment after follow-up has
been attempted, the participant can be considered to have refused
This value will be flagged as a quality check

999 No
measurement
recorded

No total cholesterol measurement was taken or recorded
This value will be flagged as an error

ANALYSIS AND USE

To identify participants who are unaware that they have high or borderline high cholesterol and need
preventive services or referral to medical management
To determine cholesterol control and management
To assess the percentage of WISEWOMAN participants who have high cholesterol or borderline
high cholesterol
To assess the risk in the WISEWOMAN population for cardiovascular disease
To provide data element required to determine participant’s cardiovascular risk score

45

Item 14b: HDL

HDL Cholesterol (fasting or nonfasting)
This variable indicates the participant’s HDL cholesterol level.

SOURCE

Not applicable; health screening measurement

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

HDL cholesterol
in mg/dL

A three-digit (numeric) value representing the participant’s HDL cholesterol in
mg/dL
HDL cholesterol values that are between 155 and 196 mg/dL will be flagged
for quality checks and program verification. Values outside 007-196 mg/dL will
be considered errors. See Appendix B for the procedure for validating out-ofrange values
Example: 90 mg/dL = 090

777 Inadequate
blood sample

HDL cholesterol measurement was attempted, but results were not obtained
due to technical difficulties or errors
This may include issues such as (1) two or more failed venipuncture attempts;
(2) insufficient amount of blood, type of test tube; (3) invalid Cholestech
readings due to very high/low values;(4) sample submitted to laboratory, test
not done due to erroneous or missing laboratory request or other paperwork
See Appendix B for the procedure for documenting the reason that the
measurement was not obtained
This value will be flagged as a quality check

888 Client
refused

Participant refuses to have her blood drawn for cholesterol measurements
If the participant refuses to go to the lab, the participant can be considered to
have refused
If the participant does not go to the scheduled lab appointment after follow-up
has been attempted, the participant can be considered to have refused
This value will be flagged as a quality check

999 No
measurement
recorded

No HDL cholesterol measurement was taken or recorded
This value will be flagged as an error

ANALYSIS AND USE

To identify participants who are unaware that they have low HDL cholesterol and need preventive
services or referral to medical management
To assess the percentage of WISEWOMAN participants who have high cholesterol or borderline
high cholesterol
To assess the risk of the WISEWOMAN population for cardiovascular disease
To assist in determining cholesterol control and management

46

Item 14c: LDL
SOURCE
DENOMINATOR
POPULATION
VALUES AND
DESCRIPTION

LDL Cholesterol (fasting)
This variable indicates a fasting participant’s fasting LDL cholesterol level.
Not applicable; health screening measurement
The denominator includes all WISEWOMAN participants with a valid baseline screening
LDL
cholesterol in
mg/dL

777
Inadequate
blood sample

888 Client
refused

999 No
measurement
recorded
ANALYSIS AND USE

A three-digit (numeric) value representing a fasting participant’s fasting LDL
cholesterol in mg/dL
LDL cholesterol values that are between 344 and 380 mg/dL will be flagged for
quality checks and program verification. Values outside 020-380 mg/dL will be
considered errors. See Appendix B for the procedure for validating out-of-range
values
For nonfasting participants, any value in this field will be flagged for a quality
check
Example: 90 mg/dL = 090
LDL cholesterol measurement was attempted, but results were not obtained due
to technical difficulties or errors
This may include issues such as (1) two or more failed venipuncture attempts; (2)
insufficient amount of blood, type of test tube; (3) invalid Cholestech readings
due to very high/low values; (4) sample submitted to laboratory, test not done
due to erroneous or missing laboratory request or other paperwork
This response should be used for participants who were confirmed to be fasting,
but their LDL cholesterol was unable to be obtained
For nonfasting participants, This value will be flagged as a quality check because
all nonfasting participants should have their LDL cholesterol coded as ‘999 No
measurement recorded’
Participant refuses to receive a lipid panel that would include LDL measurements
This response should be used for participants who were confirmed to be fasting,
but refused a lipid panel
For nonfasting participants, This value will be flagged as a quality check because
all nonfasting participants should have their LDL cholesterol coded as ‘999 No
measurement recorded’
No LDL cholesterol measurement was taken or recorded
Nonfasting participants should always have this value

To assist in determining cholesterol control and management

47

Item 14d: Trigly
SOURCE
DENOMINATOR
POPULATION
VALUES AND
DESCRIPTION

Triglycerides (fasting)
This variable indicates a fasting participant’s triglycerides measurement.
Not applicable; health screening measurement
The denominator includes all WISEWOMAN participants with a valid baseline screening
Triglycerides
in mg/dL

7777
Inadequate
blood sample

8888 Client
refused

ANALYSIS AND USE

A four-digit (numeric) value representing a fasting participant’s triglycerides
measurement in mg/dL
Triglycerides values values between 1,000 and 3,000 mg/dL will be flagged for
quality checks and program verification. Values outside 0012-3000 mg/dL will be
considered errors. See Appendix B for the procedure for validating out-of-range
values
For nonfasting participants any value in this field will be flagged for a quality check
Example: 90 mg/dL = 0090
Triglycerides measurement was attempted, but results were not obtained due to
technical difficulties or errors
This may include issues such as (1) two or more failed venipuncture attempts; (2)
insufficient amount of blood, type of test tube; (3) invalid Cholestech readings due
to very high/low values; (4) sample submitted to laboratory, test not done due to
erroneous or missing laboratory request or other paperwork
This response should be used for participants who were confirmed to be fasting, but
their triglycerides measurement could not be obtained
For nonfasting participants, This value will be flagged as a quality check because all
nonfasting participants should have their triglycerides measurement coded as ‘9999
No measurement recorded’
Fasting participant refuses to receive a lipid panel that would include triglycerides
measurements
This response should be used for participants who were confirmed to be fasting, but
refused a lipid panel
For nonfasting participants, This value will be flagged as a quality check because all
nonfasting participants should have their triglycerides measurement coded as ‘9999
No measurement recorded’
No triglycerides measurement was taken or recorded
Nonfasting participants should always have this value

9999 No
measurement
recorded
To assist in determining cholesterol control and management

48

Item 15a: Glucose

Glucose (fasting)
This variable indicates the participant’s fasting glucose measurement.

SOURCE

American Heart Association

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

Total glucose in mg/dL

Up to a three-digit (numeric) value representing the participant’s
fasting glucose level in mg/dL
Glucose values that are between 037 and 050 mg/dL or 275 and 571
mg/dL will be flagged for quality checks and program verification.
Values outside 037-571 will be considered errors. See Appendix B for
the procedure for validating out-of-range values
Example: 90 mg/dL = 090

777 Inadequate blood
sample

Glucose measurement was attempted, but results were not obtained
due to technical difficulties or errors
See Appendix B for the procedure for documenting the reason that
the measurement was not obtained
This may include issues such as (1) two or more failed venipuncture
attempts; (2) insufficient amount of blood, type of test tube; (3) invalid
Cholestech readings due to very high/low values; (4) sample
submitted to laboratory, test not done due to erroneous or missing
laboratory request or other paperwork
This value will be flagged as a quality check

888 Client refused

Participant refuses to have her blood drawn for glucose
measurements
If the participant refuses to go to the lab, the participant can be
considered to have refused
If the participant does not go to the scheduled lab appointment after
follow-up has been attempted, the participant can be considered to
have refused

999 No measurement
recorded

No glucose measurement was taken or record
Non-fasting participants should always have this value

ANALYSIS AND USE

To identify participants who have pre-diabetes and diabetes
To assist in determining diabetes control and management
To use in conjunction with A1C percentage to accurately assess a participant’s blood glucose
To provide data element required to determine participant’s cardiovascular risk score
To understand the overall rate of diabetes among the WISEWOMAN population

49

Item 15b: A1C

A1C Percentage
This variable indicates the participant’s A1C percentage (if measured).

SOURCE

Not applicable; health screening measurement

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

A1C percentage

Numeric value representing the participant’s A1C percentage. A1C
should be reported to one decimal point
If A1C was measured by another provider within the last 3 months,
it is acceptable to input the value if it is available
A1C values between 02.8% and 04.0% or 13.0% and 16.2% will
be flagged for quality checks and program verification. Values
outside 02.8%-16.2% will be considered errors. See Appendix B
for the procedure for validating out-of-range values
Example: 8.5% = 08.5 (where the decimal place counts as part of
the variable length)

7777 Inadequate blood
sample

A1C measurement was attempted, but results were not obtained
due to technical difficulties or errors
This value will be flagged as a quality check

8888 Client refused

Participant refuses to have an A1C test
If a participant refuses to go to the lab, the participant can be
considered to have refused
If a participant does not go to the scheduled lab appointment after
follow-up has been attempted, the participant can be considered to
have refused

9999 No measurement
recorded

No A1C measurement was taken or recorded

ANALYSIS AND USE

To identify participants who have diabetes and refer them for medical management
To identify participants who have higher-than-optimal A1C levels and would benefit from
preventive services such as lifestyle programs
To assist in determining diabetes control and management
To assess the cardiovascular disease risk factors in the WISEWOMAN population
To provide data element required to determine participant’s cardiovascular risk score

50

Item 16a: BPAlert

Is a medical follow-up for blood pressure reading necessary?
This variable indicates the status of medical follow-up for a participant’s alert level blood pressure.

SOURCE

Not applicable; health screening measurement

DENOMINATOR
POPULATION

Participants who have an alert level blood pressure value are included in the denominator

VALUES AND
DESCRIPTION

1 Medically necessary

Clinical follow-up for blood pressure is medically necessary

2 Not medically needed

Clinical follow-up for blood pressure is not medically necessary

3 Medically necessary
follow-up appointment
declined

Clinical follow-up for blood pressure is medically necessary but
participant declined to attend a follow-up appointment

8 Client refused workup

Participant had an alert level blood pressure reading but refused
workup

9 No answer recorded

No answer recorded. This value will be flagged as an error.

ANALYSIS AND USE

To assess whether participants with alert level blood pressure readings are receiving a workup
To assist in determining hypertension (high blood pressure) management, and control

51

Item 16b: BPDiDate

What is the date of the medically necessary follow-up appointment?
This variable indicates the folliow-up appointment date for a participant with an alert level blood
pressure reading.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

Participants who have an alert level blood pressure value are included in the denominator

VALUES AND
DESCRIPTION

Medically Necessary
Follow-up Appointment
Date

ANALYSIS AND USE

To assess whether providers are performing timely workups for participants with alert level blood
pressure values
To determine whether programs are meeting the guideline of workups within one week of the
screening for alert participants
To assist in determining hypertension (high blood pressure) prevention, management, and control

Valid date in MMDDCCYY format
If follow-up information is provided for this referral, the workup date
can be entered
Example: September 10, 2013 = 09102013

52

Item 17a: RRCComplete

Risk Reduction Counseling Completion Date
This variable indicates the date that risk reduction counseling was completed.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

Risk reduction
counseling follow-up
date

Valid date in MMDDCCYY format
Date must occur within the submission period
Example: September 10, 2013 = 09102013

88888888 Participant
refused further program
contact

Participant refused further program contact
This value will be flagged as a quality check

99999999 Participant
lost to follow-up

Provider made three attempts to follow-up with participant but
participant lost to follow-up.
This value will be flagged as a quality check

ANALYSIS AND USE

To determine the date of a completed risk reduction counseling session
To facilitate analysis of changes in risk reduction counseling provision over time

53

Item 18a: RefDate

Lifestyle Program (LSP) / Health Coaching (HC) Referral Date
This variable indicates the date that a referral to a LSP/HC occurred.

FORMAT

Type:
Item Length:
Field Length:
Leading Zeros:
Static Field:

Numeric
8
16
Yes
No

Other Format:
Justification:
Beginning Position:
Valid Range:

MMDDCCYY
Right
374
Valid date

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

Lifestyle Program/Health
Coaching Referral Date

ANALYSIS AND USE

To determine the date of the referral to a LSP/HC
To assist in determining whether the participant has received a referral to a LSP/HC
To assist in determining the number of LSP/HC referrals per participant
To facilitate analysis of changes in LSP/HC referrals over time

Valid date in MMDDCCYY format
Date must occur within the submission period
Example: September 10, 2013 = 09102013

54

Item 19a: LSPHCRec

Number of Lifestyle Program (LSP) / Health Coaching (HC) Sessions Received by the
Participant During the Screening Cycle
This variable indicates the number of LSP/HC sessions the participant has received during the
current screening cycle.

FORMAT

Type:
Item Length:
Field Length:
Leading Zeros:
Static Field:

Numeric
2
2
Yes
No

Other Format:
Justification:
Beginning Position:
Valid Range:

N/A
Right
390
Cannot be blank if
RefDate is valid

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

Number of Sessions

ANALYSIS AND USE

To track the number of LSP/HC sessions that the participant has received
To assess LSP/HC sessions in context of types and settings, and readiness to change of a
participant

Value representing the number of LSP/HC sessions the participant has
received during the current screening cycle
Example: 6 visits = 06

55

Item 19b: Intervention

Date of Lifestyle Program (LSP) / Health Coaching (HC) Session
For LSP/HC records, this variable indicates the date that the LSP/HC session occurred.

FORMAT

Type:
Item Length:
Field Length:
Leading Zeros:
Static Field:

Numeric
8
128
Yes
No

Other Format:
Justification:
Beginning Position:
Valid Range:

MMDDCCYY
Right
392
Valid date

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

All LSP/HC sessions among WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

Lifestyle Program/Health
Coaching Session Date

ANALYSIS AND USE

To determine the date of the LSP/HC session
To assist in determining whether the participant has received an LSP/HC session
To assist in calculating the number of LSP/HC sessions per participant
To assess whether participants with risk factors receive LSP/HC services
To assess changes in risk profile between participants who participate in the LSP/HC and
participants who do not

Valid date in MMDDCCYY format
Date must occur within the submission period
Example: September 10, 2013 = 09102013

56

Item 19c: LSPHCID

Lifestyle Program (LSP) / Health Coaching (HC) ID
This variable indicates which LSP/HC was used.

FORMAT

Type:
Item Length:
Field Length:
Leading Zeros:
Static Field:

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

All LSP/HC sessions among WISEWOMAN participants with a valid baseline screening

VALUES AND
DESCRIPTION

Lifestyle Program ID

Value representing the ID code of the LSP as assigned

Health Coaching ID

Value representing the ID code of the HC as assigned

ANALYSIS AND USE

Character
10
160
N/A
No

Other Format:
Justification:
Beginning Position:
Valid Range:

N/A
Left
520
Valid code for an
LSP/HC; cannot be
blank if a valid date is
provided for Intervention

To track the number of WISEWOMAN participants who receive an LSP/HC session from each
WISEWOMAN LSP/HC provider
To describe differences in participant demographics or other characteristics by LSP/HC provider
To identify the number of LSP/HC providers in a given geographic area

57

Item 20a: TobResDate

Date of Referral to Tobacco Cessation Resource
This variable indicates the date that the referral to a tobacco cessation resource occurred.

FORMAT

Type:
Item Length:
Field Length:
Leading Zeros:
Static Field:

Numeric
8
24
Yes
No

Other Format:
Justification:
Beginning Position:
Valid Range:

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

WISEWOMAN participants with a valid baseline screening wwho identify themselves as current
smokers

VALUES AND
DESCRIPTION

Tobacco Cessation
Resource Referral Date

ANALYSIS AND USE

To document the date of a referral to tobacco cessation resource
To assist in tracking receipt of tobacco cessation resource

Valid date in MMDDCCYY format
Date must occur within the submission period
Example: September 10, 2013 = 09102013

58

MMDDCCYY
Right
776
Valid date; cannot be
blank if RRCSmoke =1

Item 20b: TobResType

Type of Tobacco Cessation Resource
This variable indicates the type of tobacco cessation resource that the participant was referred to.

FORMAT

Type:
Item Length:
Field Length:
Leading Zeros:
Static Field:

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

WISEWOMAN participants with a valid baseline screening who identify themselves as current
smokers

VALUES AND
DESCRIPTION

1 Quit line

Participant was referred to a proactive tobacco quit line

2 Community-based tobacco
program

Participant was referred to a community-based tobacco
program

3 Other tobacco cessation
resources

Participant was referred to other tobacco cessation
resources

9 No answer recorded

No answer was recorded
This value will be flagged as an error if a valid date is
provided for TobResDate

ANALYSIS AND USE

Numeric
1
3
No
No

Other Format:
Justification:
Beginning Position:
Valid Range:

N/A
Right
800
See values; cannot be
blank if valid date is
provided for
TobResDate

To determine the number of smokers that received a referral to tobacco cessation resource
To determine how frequently different types of tobacco cessation resources are being used within
and across programs
To compare the smoking status at rescreening and follow-up of women who were linked to tobacco
cessation resources versus those who were not

59

Item 20c: TResComp

Tobacco Cessation Activity Completed
This variable indicates whether the participant completed tobacco cessation activity.

FORMAT

Type:
Item Length:
Field Length:
Leading Zeros:
Static Field:

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

WISEWOMAN participants with a valid baseline screening who identify themselves as current
smokers

VALUES AND
DESCRIPTION

1 Yes – Completed tobacco
cessation activity

Participant completed tobacco cessation activity

2 No – Partially completed
tobacco cessation activity

Participant partially completed tobacco cessation activity

3 No – Discontinued from tobacco
cessation activity when reached

Participant decided to discontinue from tobacco cessation
counseling when contacted by the tobacco cessation
resource

4 No – Could not reach to conduct
tobacco cessation activity

Participant could not be reached when contacted by the
tobacco cessation resource

9 No answer recorded

No answer was recorded
This value will be flagged as an error if a valid date is
provided for TobResDate

ANALYSIS AND USE

Numeric
1
3
No
No

Other Format:
Justification:
Beginning Position:
Valid Range:

N/A
Right
803
See values; cannot be
blank if valid date is
provided for
TobResDate

To determine the number of smokers that participated in tobacco cessation activities
To compare the smoking status at rescreening and follow-up of women who were linked to tobacco
cessation resources versus those who were not

60